Posted in News
EpiAxis Phase 1 FPI News Release
Posted by Admin 2 years ago
The trial has commenced.
There is currently no therapy to fight recurrent, metastatic breast cancer, which is the major source of death in women with breast cancer. Furthermore, current first-line treatments have extensive side-effects.We are determined to fix that.
Subscribe to our newsletter